Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis
SHANGHAI, March 25, 2026 /PRNewswire/ -- Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III clinical trial of HMI-115, its first-in-class...
Alliance for tomorrow: tesa, ZEISS, Saint-Gobain Sekurit, and Hyundai Mobis unite to revolutionize windshield display technology
New one-stop solution: Production-ready holographic windshield displays for OEMs Smart windshields: Holography turns glass into transparent info- and infotainment interfaces Industrialization by 2029: Alliance ensures reliable, cost-efficient series...
Hyundai Mobis Secured Over 9 Billion USD in Orders from Global Automakers Last Year
- Secured 9.17 billion USD in orders, exceeding the core components target (7.45 billion USD) by 23% despite EV chasm - Diverse advanced portfolio, including Battery Systems Assembly (BSA) and next-gen electronic components, drove results - Customer...
AIMOTIVE AND LG TO UNVEIL ADVANCED INTEGRATED IVI/ADAS CONTROLLER AT CES 2026
BUDAPEST, Hungary, Dec. 18, 2025 /PRNewswire/ -- aiMotive, a leading developer of advanced artificial intelligence and automated driving software, in collaboration with LG, will introduce a next-generation High-Performing Computing (HPC) Lite...
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development
HMI-115 received FDA Fast Track Designation based on results from a Phase II clinical trial for endometriosis Mean dysmenorrhea pain score reduced by 42% Mean non-menstrual chronic pelvic pain score reduced by 52% Most patients maintained normal...
Huawei Li Peng: Maximizing 5G Network Value in the Age of AI
BARCELONA, Spain, March 4, 2025 /PRNewswire/ -- At MWC Barcelona 2025, Li Peng, Huawei's Corporate Senior Vice President and President of ICT Sales & Service, delivered a keynote on how carriers can make the most of AI to fully unleash the value...